Streetbeat News

Regulatory

GOOG

MDB

MongoDB has announced that its Atlas for Government platform now supports Google Cloud's Assured Workloads, enhancing flexibility and resilience for public sector organizations. This makes MongoDB Atlas the first multi-cloud data platform authorized at FedRAMP Moderate.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:03 pm

EXAS

Exact Sciences Corp. has launched a Multi-Cancer Early Detection study with 25,000 patients, supported by FDA authorization. The study aims to evaluate the clinical performance and impact of MCED testing over five years.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 11:07 am

JNJ

Johnson & Johnson received FDA approval for RYBREVANT and LAZCLUZE, a new chemotherapy-free treatment for certain types of lung cancer. This marks a significant milestone as it is the first multitargeted regimen approved for EGFR-mutated NSCLC.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 11:05 am

BA

GCAD

ITA

Boeing shares are trading lower premarket due to FAA's directive for inspections on 787 Dreamliners following a mid-air incident. Boeing also halted 777-9 test flights due to a component issue. The stock is down 0.97% premarket.

Portfolio Pulse from Lekha Gupta

August 20, 2024 | 10:41 am

GSK

The FDA has granted Breakthrough Therapy Designation to GSK's investigational drug GSK5764227, which targets B7-H3 for treating extensive-stage small-cell lung cancer that has progressed after platinum-based chemotherapy.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 10:34 am

TSLA

The European Union is set to impose a 19% tariff on Tesla vehicles imported from China. This move could impact Tesla's pricing strategy and sales in the European market.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 10:32 am

ELAN

Elanco Animal Health announced that the FDA has completed its review of all major and minor technical sections for Credelio Quattro, a broad-spectrum parasiticide. The final 60-day administrative review is underway, with US approval expected in October and a launch planned for Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 10:29 am

BABA

BIDU

JD

LI

NIO

Major Chinese stocks, including Alibaba, NIO, and Baidu, are trading lower in premarket due to China's decision to stop releasing daily foreign fund flow data, causing investor anxiety. This move comes amid China's economic challenges, including a struggling property sector and weak consumer sentiment.

Portfolio Pulse from Benzinga Neuro

August 20, 2024 | 9:30 am

AZN

China's National Medical Products Association has approved AstraZeneca's Fasenra (Benralizumab) for the maintenance treatment of severe eosinophilic asthma in patients aged 12 and older.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:58 am

AAPL

TNDM

Tandem Diabetes Care is releasing an update for its iOS t:connect app to fix a battery issue in its t:slim X2 insulin pump, which can lead to serious health risks. The update is set for August 20, 2024, following a March recall.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 6:59 am